Effectiveness of hepatitis A vaccination as post-exposure prophylaxis
Ignasi Parrón(Generalitat de Catalunya), Núria Torner(Centro de Investigación Biomédica en Red), Ana Martı́nez(Consejo Superior de Investigaciones Científicas), Ángela Domı́nguez(Instituto de Salud Carlos III), Mireia Jané(Generalitat de Catalunya), Sofía Minguell(Generalitat de Catalunya), Pere Godoy(Servicio Canario de la Salud), María Rosa Sala(Generalitat de Catalunya), Sandra Manzanares-Laya(Agència de Salut Pública de Catalunya), Caritat Planas(Generalitat de Catalunya)
Cited by 22
Related Papers
COVID-19: Drug Targets and Potential Treatments
|Journal of Medicinal Chemistry|2020|469
First Non-ATP Competitive Glycogen Synthase Kinase 3 β (GSK-3β) Inhibitors: Thiadiazolidinones (TDZD) as Potential Drugs for the Treatment of Alzheimer's Disease
|Journal of Medicinal Chemistry|2002|448
Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza
|Critical Care|2009|382
GSK-3 Inhibitors: Preclinical and Clinical Focus on CNS
|Frontiers in Molecular Neuroscience|2011|348
Glycogen synthase kinase 3 (GSK‐3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation
|Medicinal Research Reviews|2002|334